August 21, 2018 : DCMS #411

DISASTERS AVERTED — Near Miss Case Studies

What NOT to Do When Your Patient is a Colleague

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Dace Trence on CGM and How Diabetes Testing and Care are Changing

HOMERUN SLIDES — Great Clinical Presentation Highlights

Eversense CGM System Part 1

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #139: The Genetics of Type 2 Diabetes Part 1

MOST POPULAR ARTICLES OF THE MONTH

#1 37-Year-Old Hypertensive Drug Improves Beta Cell Function and Insulin Production
#2 Vitamin D Supplementation for Diabetes Prevention
#3 Omnipod Insulin Delivery System Receives FDA Clearance

As is often the case, once we provide you with a cutting edge interview or new product, many of you ask for a much increased explanation, and a deeper knowledge base.

Last week in our Diabetes Mastery newsletter, we had an interview with Dr. Stanley Schwartz where he discussed his ways of classifying and treating diabetes. This week, we delve into the genetics of type 2 diabetes in our Clinical Gem to help give you more background on why treatments need to be individualized.

Our newsletter on Saturday had a great article on the use of CGM, and this week we have the beginning of a new slide series on how the first implantable CGM has the opportunity to change even more the management of diabetes.

Dave Joffe

Editor-in-chief

Health care professionals who are endocrinologists, cardiologists or who work in these specialized fields know the complications of prediabetes or diabetes. Many of us have these patients. Sometimes it’s almost natural to talk with these patients differently than we’d talk with most of our patients who aren’t as well-educated.

A woman, 59 years of age with prediabetes and strong history of cardiovascular disease complained of a slight chest pain not associated with exertion or shortness of breath, just an ongoing discomfort. Other than this, the patient — who is herself a health care provider —  is feeling fine.

Dace L. Trence, MD, FACE received her MD degree from the University of Minnesota Medical School.  She completed an internal medicine residency through Northwestern Hospital in Minneapolis and, subsequently, returned to the University of Minnesota for Endocrine Fellowship.  Dr. Trence started practice with Group Health, Inc, in Minnesota, becoming Chief of Endocrinology, initiating several programs, including a Lipids Clinic, Diabetes Foot Care Clinic, and a Diabetes and Pregnancy Clinic.  After moving to Seattle to practice at Group Health of Puget Sound, becoming Chief of Endocrinology, then Chief of Medical Subspecialties, she then joined the faculty at the University of Washington. Currently she is a Professor in the Department of Medicine,  Director of the Diabetes Care Center and Director of the Endocrine Fellowship Program at the University of Washington.

In this week’s Homerun Slides, we begin a review of the new Eversense CGM system.

The diabetic spectrum: Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of different organs, especially the eyes, kidneys, nerves, heart, and blood vessels.

Researchers discover safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset type 1.

Vitamin D shows potential to lower HbA1c, FPG, insulin resistance, and 2-hour post-prandial glucose levels.

The Omnipod Dash™ device approved for commercialization and release in the U.S. by mid-2018.